The report is titled ‘Blood Plasma Market: Opportunity Analysis and Future Assessment 2020-2028’. An overview of conceptual frameworks, analytical approaches of the blood plasma market is the main objective of the report, which further consists of the market opportunity and insights of the data involved in the making of the respective market. The blood plasma market is expected to grow at significant rate in the near future.
The global blood plasma market in 2020 is estimated for more than US$ 21.1 Bn and expected to reach at a value of US$ 35.4 Bn by 2028 with a significant CAGR of 6.7%.
Blood Plasma Market Definition
The liquid portion of the blood is basically known as plasma that regulates the body temperature and blood pressure. The major purpose of the plasma is that it acts as a model for the transfer of proteins, nutrients, and hormones to the other body parts. The plasma consists of more than a hundred crucial proteins such as clotting factor, immunoglobulin, fibrinogen, and protease inhibitors.
Plasma is considered as a substance and protein and is utilized as a major component in clinical products to substitute the body fluids, antibodies, and clotting factors. The procedure of medical care for autoimmune disorders and hemophilia includes plasma as an essential element.
The soaring prevalence of several chronic and life-threatening diseases among the population is majorly driving the growth of the global blood plasma market across the globe.
Blood Plasma Market Dynamics
A huge upsurge in the count of patients suffering from hemophilia across the world is one of the major drivers that is estimated to propel the growth of the blood plasma market as there is increased use of plasma for the treatment of hemophilia.
By the same token, the sluggish lifestyle of the population comprising unhealthy diets and no physical activity coupled with the growing geriatric population is also adding to the rising life-threatening ailments across the world, further boosting the demand for blood plasma in the market.
Therefore, the global blood plasma market is projected to witness rapid growth in the forthcoming years. Along with that, an advance in the knowledge and awareness among the population with respect to blood plasma derivatives and donation of blood and plasma donation is also expected to give a breakthrough to the growth of the blood plasma market during the forecast timeframe.
In addition to that, the evolution in the healthcare industry and surging technological advancements in the diagnostics and treatment provided to patients has resulted in the development of plasma-derived therapeutic protein drugs, thereby augmenting the demand of blood plasma in the market.
Hence, the blood plasma market is expected to grow substantially in the coming years. However, the inadequate understanding and awareness about blood plasma in a few emerging regions along with its high cost may hold back the growth of the blood plasma market in the near future.
Blood Plasma Market Segmentation
The blood plasma market is segmented on the basis of blood plasma types, applications, end-user, and regions.
On Basis of Blood Plasma Types
• Immunoglobulin
o Intravenous Immunoglobulin
o Subcutaneous Immunoglobulin
o Other Immunoglobulin Type
• Albumin
• Hyperimmune
• Coagulation Factor Concentrates
• Other Plasma Fractionation Products
By End Users
• Hospitals
• Clinics
• Research laboratories
• Academic institutions
By Application
• Immunology
• Oncology
• Pulmonology
• Rheumatology
• Transplantation
• Neurology
• Haematology
• Other Applications
Blood Plasma Market Key Players
Some of the key participating players in blood plasma market are Adma Biologics Inc., Baxter International Inc., Cerus Corp., Octopharma Ag, and others
MMC Overview on Blood Plasma Market Report
The non-identical approach of Meridian Market Consultants stands with conceptual methods backed up with the data analysis. The novel market understanding approach makes up the standard of the assessment results that give better opportunity for the customers to put their effort.
A research report on the Blood Plasma market by Meridian Market Consultants is an in-depth and extensive study of the market based on the necessary data crunching and statistical analysis. It provides a brief view of the dynamics flowing through the market, which includes the factors that support market and the factors that are acting as impedance for the growth of the market.
Furthermore, the report includes the various trends and opportunities in the respective market in different regions for a better understanding of readers that helps to analyze the potential of the market.
Factors that are benchmarked while estimating the market
Various factors that are benchmarked while estimating the market growth include (but not restricted to):
• New product designs and launches
• Current product compliance
• Reimbursement
• Concerns for use of Blood Plasma
• Advantages of Blood Plasma over other modalities
Actions taken by the manufacturer and respective regulatory authorities also impact the market growth of the segment. These factors are understood at the regional level and in major countries globally for providing regional insights of the product segment in the report. This helps our clients to make an informed decision.
A mix of top-down and bottom-up approach is followed to arrive and validate our market value estimations. For a product segment wherein one/two manufacturer(s) dominates the market, it’s products sales, previous growth rates and market expansion plans are considered to generate market share in the global market.
1. Global Blood Plasma Market Report Overview
1.1. Introduction
1.2. Report Description
1.3. Methodology
2. Global Blood Plasma Market Overview
2.1. Introduction
2.1.1. Market Definition
2.1.2. Market Taxonomy
2.2. Executive Summary
2.3. Global Blood Plasma Market Snapshot
2.4. Global Blood Plasma Market Size and Forecast, 2020–2028
2.4.1. Introduction
2.4.2. Market Value Forecast and Annual Growth Rate (AGR) Comparison (2020–2028)
2.5. Global Blood Plasma Market Dynamics
2.5.1. Drivers
2.5.2. Restraints
2.5.3. Opportunity
2.5.4. Trends
2.6. Key Regulations
2.7. Porter’s Five Forces Model
3. Global Blood Plasma Market, By Blood Plasma Types
3.1. Introduction
3.1.1. Annual Growth Rate Comparison, By Blood Plasma Types
3.1.2. BPS Analysis, By Blood Plasma Types
3.2. Market Revenue (US$Mn) Forecast, By Blood Plasma Types
3.2.1. Immunoglobulin
3.2.1.1. Intravenous Immunoglobulin
3.2.1.2. Subcutaneous Immunoglobulin
3.2.1.3. Other Immunoglobulin Type
3.2.2. Albumin
3.2.3. Hyperimmune
3.2.4. Coagulation Factor Concentrates
3.2.5. Other Plasma Fractionation Products
3.3. Global Blood Plasma Market Attractiveness Index, By Blood Plasma Types
4. Global Blood Plasma Market, By End Users
4.1. Introduction
4.1.1. Annual Growth Rate Comparison, By End Users
4.1.2. BPS Analysis, By End Users
4.2. Market Revenue (US$Mn) Forecast, By End Users
4.2.1. Hospitals
4.2.2. Clinics
4.2.3. Research laboratories
4.2.4. Academic institutions
4.3. Global Blood Plasma Market Attractiveness Index, By End Users
5. Global Blood Plasma Market, By Application
5.1. Introduction
5.1.1. Annual Growth Rate Comparison, By Application
5.1.2. BPS Analysis, By Application
5.2. Market Revenue (US$Mn) Forecast, By Application
5.2.1. Immunology
5.2.2. Oncology
5.2.3. Pulmonology
5.2.4. Rheumatology
5.2.5. Transplantation
5.2.6. Neurology
5.2.7. Haematology
5.2.8. Other Applications
5.3. Global Blood Plasma Market Attractiveness Index, By Application
6. Global Blood Plasma Market, By Region
6.1. Introduction
6.1.1. Annual Growth Rate Comparison, By Region
6.1.2. BPS Analysis, By Region
6.2. Market Revenue (US$Mn) Forecast, By Region
6.2.1. North America
6.2.2. Latin America
6.2.3. Europe
6.2.4. Asia Pacific
6.2.5. Middle East
6.2.6. Africa
6.3. Global Blood Plasma Market Attractiveness Index, By Region
7. North America Blood Plasma Market Analysis and Forecast, 2020–2028
7.1. Introduction
7.1.1. Annual Growth Rate Comparison, By Country
7.1.2. BPS Analysis, By Country
7.2. Market Revenue (US$Mn) Forecast, By Country
7.2.1. U.S. Blood Plasma Market
7.2.2. Canada Blood Plasma Market
7.3. North America Blood Plasma Market, By Blood Plasma Types
7.3.1. Immunoglobulin
7.3.1.1. Intravenous Immunoglobulin
7.3.1.2. Subcutaneous Immunoglobulin
7.3.1.3. Other Immunoglobulin Type
7.3.2. Albumin
7.3.3. Hyperimmune
7.3.4. Coagulation Factor Concentrates
7.3.5. Other Plasma Fractionation Products
7.4. North America Blood Plasma Market, By End Users
7.4.1. Hospitals
7.4.2. Clinics
7.4.3. Research laboratories
7.4.4. Academic institutions
7.5. North America Blood Plasma Market, By Application
7.5.1. Immunology
7.5.2. Oncology
7.5.3. Pulmonology
7.5.4. Rheumatology
7.5.5. Transplantation
7.5.6. Neurology
7.5.7. Haematology
7.5.8. Other Applications
7.6. North America Blood Plasma Market Attractiveness Index
7.6.1. By Country
7.6.2. By Blood Plasma Types
7.6.3. By End Users
7.6.4. By Application
8. Latin America Blood Plasma Market Analysis and Forecast, 2020–2028
8.1. Introduction
8.1.1. Annual Growth Rate Comparison, By Country
8.1.2. BPS Analysis, By Country
8.2. Market (US$Mn) Forecast, By Country
8.2.1. Brazil Blood Plasma Market
8.2.2. Mexico Blood Plasma Market
8.2.3. Argentina Blood Plasma Market
8.2.4. Rest of Latin America Blood Plasma Market
8.3. Latin America Blood Plasma Market, By Blood Plasma Types
8.3.1. Immunoglobulin
8.3.1.1. Intravenous Immunoglobulin
8.3.1.2. Subcutaneous Immunoglobulin
8.3.1.3. Other Immunoglobulin Type
8.3.2. Albumin
8.3.3. Hyperimmune
8.3.4. Coagulation Factor Concentrates
8.3.5. Other Plasma Fractionation Products
8.4. Latin America Blood Plasma Market, By End Users
8.4.1. Hospitals
8.4.2. Clinics
8.4.3. Research laboratories
8.4.4. Academic institutions
8.5. Latin America Blood Plasma Market, By Application
8.5.1. Immunology
8.5.2. Oncology
8.5.3. Pulmonology
8.5.4. Rheumatology
8.5.5. Transplantation
8.5.6. Neurology
8.5.7. Haematology
8.5.8. Other Applications
8.6. Latin America Blood Plasma Market Attractiveness Index
8.6.1. By Country
8.6.2. By Blood Plasma Types
8.6.3. By End Users
8.6.4. By Application
9. Europe Blood Plasma Market Analysis and Forecast, 2020–2028
9.1. Introduction
9.1.1. Annual Growth Rate Comparison, By Country
9.1.2. BPS Analysis, By Country
9.2. Market (US$Mn) Forecast, By Country
9.2.1. U.K. Blood Plasma Market
9.2.2. Germany Blood Plasma Market
9.2.3. Italy Blood Plasma Market
9.2.4. France Blood Plasma Market
9.2.5. Spain Blood Plasma Market
9.2.6. Russia Blood Plasma Market
9.2.7. Poland Blood Plasma Market
9.2.8. BENELUX Blood Plasma Market
9.2.9. NORDIC Blood Plasma Market
9.2.10. Rest of Europe Blood Plasma Market
9.3. Europe Blood Plasma Market, By Blood Plasma Types
9.3.1. Immunoglobulin
9.3.1.1. Intravenous Immunoglobulin
9.3.1.2. Subcutaneous Immunoglobulin
9.3.1.3. Other Immunoglobulin Type
9.3.2. Albumin
9.3.3. Hyperimmune
9.3.4. Coagulation Factor Concentrates
9.3.5. Other Plasma Fractionation Products
9.4. Europe Blood Plasma Market, By End Users
9.4.1. Hospitals
9.4.2. Clinics
9.4.3. Research laboratories
9.4.4. Academic institutions
9.5. North America Blood Plasma Market, By Application
9.5.1. Immunology
9.5.2. Oncology
9.5.3. Pulmonology
9.5.4. Rheumatology
9.5.5. Transplantation
9.5.6. Neurology
9.5.7. Haematology
9.5.8. Other Applications
9.6. Europe Blood Plasma Market Attractiveness Index
9.6.1. By Country
9.6.2. By Blood Plasma Types
9.6.3. By End Users
9.6.4. By Application
10. Asia Pacific Blood Plasma Market Analysis and Forecast, 2019–2027
10.1. Introduction
10.1.1. Annual Growth Rate Comparison, By Country
10.1.2. BPS Analysis, By Country
10.2. Market (US$Mn) Forecast, By Country
10.2.1. China Blood Plasma Market
10.2.2. India Blood Plasma Market
10.2.3. Japan Blood Plasma Market
10.2.4. Australia and New Zealand Blood Plasma Market
10.2.5. South Korea Blood Plasma Market
10.2.6. ASEAN Blood Plasma Market
10.2.7. Rest of Asia Pacific Blood Plasma Market
10.3. Asia Pacific Blood Plasma Market, By Blood Plasma Types
10.3.1. Immunoglobulin
10.3.1.1. Intravenous Immunoglobulin
10.3.1.2. Subcutaneous Immunoglobulin
10.3.1.3. Other Immunoglobulin Type
10.3.2. Albumin
10.3.3. Hyperimmune
10.3.4. Coagulation Factor Concentrates
10.3.5. Other Plasma Fractionation Products
10.4. Asia Pacific Blood Plasma Market, By End Users
10.4.1. Hospitals
10.4.2. Clinics
10.4.3. Research laboratories
10.4.4. Academic institutions
10.5. Asia Pacific Blood Plasma Market, By Application
10.5.1. Immunology
10.5.2. Oncology
10.5.3. Pulmonology
10.5.4. Rheumatology
10.5.5. Transplantation
10.5.6. Neurology
10.5.7. Haematology
10.5.8. Other Applications
10.6. Asia Pacific Blood Plasma Market Attractiveness Index
10.6.1. By Country
10.6.2. By Blood Plasma Types
10.6.3. By End Users
10.6.4. By Application
11. Middle East Blood Plasma Market Analysis and Forecast, 2019–2027
11.1. Introduction
11.1.1. Annual Growth Rate Comparison, By Country
11.1.2. BPS Analysis, By Country
11.2. Market (US$Mn) Forecast, By Country
11.2.1. GCC Countries Blood Plasma Market
11.2.2. Israel Blood Plasma Market
11.2.3. Oman Blood Plasma Market
11.2.4. Rest of Middle East Blood Plasma Market
11.3. Middle East Blood Plasma Market, By Blood Plasma Types
11.3.1. Immunoglobulin
11.3.1.1. Intravenous Immunoglobulin
11.3.1.2. Subcutaneous Immunoglobulin
11.3.1.3. Other Immunoglobulin Type
11.3.2. Albumin
11.3.3. Hyperimmune
11.3.4. Coagulation Factor Concentrates
11.3.5. Other Plasma Fractionation Products
11.4. Middle East Blood Plasma Market, By End Users
11.4.1. Hospitals
11.4.2. Clinics
11.4.3. Research laboratories
11.4.4. Academic institutions
11.5. Middle East Blood Plasma Market, By Application
11.5.1. Immunology
11.5.2. Oncology
11.5.3. Pulmonology
11.5.4. Rheumatology
11.5.5. Transplantation
11.5.6. Neurology
11.5.7. Haematology
11.5.8. Other Applications
11.6. Middle East Blood Plasma Market Attractiveness Index
11.6.1. By Country
11.6.2. By Blood Plasma Types
11.6.3. By End Users
11.6.4. By Application
12. Africa Blood Plasma Market Analysis and Forecast, 2019–2027
12.1. Introduction
12.1.1. Annual Growth Rate Comparison, By Country
12.1.2. BPS Analysis, By Country
12.2. Market (US$Mn) Forecast, By Country
12.2.1. South Africa Blood Plasma Market
12.2.2. Egypt Blood Plasma Market
12.2.3. North Africa Blood Plasma Market
12.2.4. Rest of Africa Blood Plasma Market
12.3. Africa Blood Plasma Market, By Blood Plasma Types
12.3.1. Immunoglobulin
12.3.1.1. Intravenous Immunoglobulin
12.3.1.2. Subcutaneous Immunoglobulin
12.3.1.3. Other Immunoglobulin Type
12.3.2. Albumin
12.3.3. Hyperimmune
12.3.4. Coagulation Factor Concentrates
12.3.5. Other Plasma Fractionation Products
12.4. Africa Blood Plasma Market, By End Users
12.4.1. Hospitals
12.4.2. Clinics
12.4.3. Research laboratories
12.4.4. Academic institutions
12.5. Africa Blood Plasma Market, By Application
12.5.1. Immunology
12.5.2. Oncology
12.5.3. Pulmonology
12.5.4. Rheumatology
12.5.5. Transplantation
12.5.6. Neurology
12.5.7. Haematology
12.5.8. Other Applications
12.6. Africa Blood Plasma Market Attractiveness Index
12.6.1. By Country
12.6.2. By Blood Plasma Types
12.6.3. By End Users
12.6.4. By Application
13. Recommendation
13.1. Market Strategy
14. Competitive Landscape
14.1. Competition Dashboard
14.2. List and Company Overview of Global Key Players
14.3. Company Profiles
14.3.1. Adma Biologics Inc.
14.3.1.1. Company Overview
14.3.1.2. Financial Overview
14.3.1.3. Blood Plasma Types Portfolio
14.3.1.4. Key Developments
14.3.1.5. Business Strategies
14.3.2. Baxter International Inc.
14.3.3. Cerus Corp.
14.3.4. General Electric Co.
14.3.5. Octopharma Ag
14.3.6. Others
15. Acronyms
Frequently Asked Questions
What is the projected market size & Compound Annual Growth Rate (CAGR) of the market?
The global blood plasma market in 2020 is estimated for more than US$ 21.1 Bn and expected to reach at a value of US$ 35.4 Bn by 2028 with a significant CAGR of 6.7%.
What are the key factors driving the growth of market?
A huge upsurge in the count of patients suffering from hemophilia across the world, sluggish lifestyle of the population comprising unhealthy diets and no physical activity coupled with the growing geriatric population are the key factors driving the growth of market
What segments are covered in market report?
The blood plasma market is segmented on the basis of blood plasma types, applications, end-user, and regions.
What are the key participating players in the market?
Some of the key participating players in blood plasma market are Adma Biologics Inc., Baxter International Inc., Cerus Corp., Octopharma Ag, and others
